Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
394.65
360.14
494.34
387.63
383.01
330.40
369.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
394.65
360.14
494.34
387.63
383.01
330.40
369.15
Raw Material Cost
119.56
117.47
153.74
122.69
117.64
94.71
140.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.28
0.91
0.97
0.79
0.82
0.65
0.90
Selling and Distribution Expenses
159.12
148.14
170.68
136.92
162.46
148.13
116.12
Other Expenses
2.39
2.19
1.61
1.75
2.28
1.74
2.57
Total Expenditure (Excl Depreciation)
303.83
288.41
341.53
277.93
303.70
260.83
282.97
Operating Profit (PBDIT) excl Other Income
90.8
71.7
152.79999999999998
109.7
79.3
69.6
86.19999999999999
Other Income
6.65
7.61
-7.93
1.28
-14.04
-6.59
4.37
Operating Profit (PBDIT)
120.20
106.15
159.80
137.34
86.20
86.68
102.94
Interest
1.28
0.91
0.97
0.79
0.82
0.65
0.90
Exceptional Items
2.16
0.00
-1.52
1.22
0.00
0.00
0.00
Gross Profit (PBDT)
275.09
242.67
340.60
264.94
265.37
235.69
228.95
Depreciation
29.67
29.67
26.78
26.78
25.64
25.64
24.05
Profit Before Tax
91.42
75.57
130.54
110.99
59.74
60.40
77.99
Tax
23.96
20.96
30.32
25.37
18.01
18.44
22.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
32.15
31.79
42.20
59.95
23.30
28.64
11.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
32.15
31.79
42.20
59.95
23.30
28.64
11.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
30.26
20.33
54.22
24.09
12.98
13.04
25.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
62.41
52.12
96.42
84.04
36.28
41.68
36.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,965.33
1,981.80
1,978.32
1,905.44
1,824.94
1,781.97
1,747.68
Earnings per share (EPS)
0.12
0.12
0.16
0.23
0.09
0.11
0.04
Diluted Earnings per share
0.12
0.12
0.16
0.23
0.09
0.11
0.04
Operating Profit Margin (Excl OI)
21.26%
19.12%
28.51%
28.19%
19.48%
20.47%
20.19%
Gross Profit Margin
30.68%
29.22%
31.82%
35.54%
22.29%
26.04%
27.64%
PAT Margin
8.15%
8.83%
8.54%
15.47%
6.08%
8.67%
3.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 3.03% vs 19.76% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 71.90% vs -21.77% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 13.37% vs 15.84% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 62.50% vs 14.29% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Inner Mongolia Furui Medical Science Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
394.65
0
394.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
394.65
0
394.65
Raw Material Cost
119.56
0
119.56
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.28
0
1.28
Selling and Distribution Expenses
159.12
0
159.12
Other Expenses
2.39
0.00
2.39
Total Expenditure (Excl Depreciation)
303.83
0
303.83
Operating Profit (PBDIT) excl Other Income
90.82
0.00
90.82
Other Income
6.65
0
6.65
Operating Profit (PBDIT)
120.20
0
120.20
Interest
1.28
0
1.28
Exceptional Items
2.16
0
2.16
Gross Profit (PBDT)
275.09
0
275.09
Depreciation
29.67
0
29.67
Profit Before Tax
91.42
0
91.42
Tax
23.96
0
23.96
Provisions and contingencies
0
0
0.00
Profit After Tax
32.15
0
32.15
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
32.15
0
32.15
Share in Profit of Associates
0
0
0.00
Minority Interest
30.26
0
30.26
Other related items
0.00
0.00
0.00
Consolidated Net Profit
62.41
0
62.41
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,965.33
0
1,965.33
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
21.26%
0%
0.00
21.26%
Gross Profit Margin
30.68%
0%
0.00
30.68%
PAT Margin
8.15%
0%
0.00
8.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 39.46 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 9.58% vs -27.15% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3.03% vs 19.76% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.24 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 19.77% vs -45.95% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 71.90% vs -21.77% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.36 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 15.33% vs -41.26% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 13.37% vs 15.84% in Jun 2025
Quarterly - Interest
Interest 0.13 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 44.44% vs -10.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 62.50% vs 14.29% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.26%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
